PR push looms after Campto owner shift

A PR contract for colorectal cancer brand Campto could be up for grabs within weeks as Pfizer prepares to take control of it from Aventis.

Pfizer has agreed to buy Campto for around £330m as French drugs giant Sanofi-Synthelabo bids to comply with regulatory concerns as it progresses with its acquisition of Aventis, the Franco-German firm that currently markets Campto.

A spokeswoman for Pfizer, whose acquisition of Campto is conditional on the successful completion of the Sanofi-Aventis deal, said: ‘As we normally include PR in our promotional activities, and normally include a PR or comms agency on our product teams, it is likely we may do the same with Campto.’

Aventis has formerly used various PR agencies to promote Campto although PR backing for the brand has been minimal in the past few months, with the promotional emphasis placed on medical education and sales reps.

PR for Campto was most recently handled by Interaction Marketing and Public Relations Consultants, which promoted it until February.

Other products in the bowel cancer market include Sanofi’s own Eloxatin, well-established generic treatment 5FU and Roche Pharmaceuticals’ Xeloda.

Additional PR contracts that could be up for grabs as a result of the Sanofi-Aventis deal are blood-thinning brands Fraxiparine and Arixtra, which Sanofi has agreed to transfer to GlaxoSmithKline (PRWeek, 7 May).

Before commenting please read our rules for commenting on articles.

If you see a comment you find offensive, you can flag it as inappropriate. In the top right-hand corner of an individual comment, you will see 'flag as inappropriate'. Clicking this prompts us to review the comment. For further information see our rules for commenting on articles.

comments powered by Disqus

Latest Articles

Max Clifford trial jury finishes sixth day of deliberations

Max Clifford trial jury finishes sixth day of deliberations

The jury in the trial of celebrity publicist Max Clifford on 11 charges of indecent assault has been sent home and will reconvene tomorrow morning for a seventh day of deliberations.

Analysis: Fishburn chiefs keep eyes on future despite mounting departures

Analysis: Fishburn chiefs keep eyes on future despite mounting departures

Fishburn's management have defended their reinvention of the 23-year-old agency amid industry mutterings, fed by a series of director-level departures, about the direction in which it is going.

Hit or Miss? EasyJet backs Shakespeare Day campaign with world record attempt

Hit or Miss? EasyJet backs Shakespeare Day campaign with world record attempt

EasyJet aimed to break the world record for the highest ever theatrical performance for Shakespeare's 450th birthday yesterday with the Reduced Shakespeare Company performing on a flight from Gatwick to Verona.

Top PRs to gather in Barcelona for inaugural PRWeek Global Congress

Top PRs to gather in Barcelona for inaugural PRWeek Global Congress

Senior executives from IBM, Nestlé, Vedanta, GE, Cargill, Philips and Allianz will be among the speakers at PRWeek's first Global Congress.